Literature DB >> 17597463

Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.

Bryndís Ragnarsdóttir1, Martin Samuelsson, Mattias C U Gustafsson, Irene Leijonhufvud, Diana Karpman, Catharina Svanborg.   

Abstract

Toll-like receptor (TLR) 4 is essential for the defense against infection with gram-negative pathogens, but reduced TLR4 expression has not been linked to altered disease susceptibility in humans. In mice, Tlr4 controls the mucosal response to Escherichia coli urinary tract infections. Inactivation of mouse Tlr4 causes an asymptomatic carrier state resembling asymptomatic bacteriuria (ABU). The present study compared neutrophil TLR4 expression levels between children with ABU (n=17) and age-matched control subjects (n=24), and significantly lower levels were detected in the patients with ABU. We also found elevated levels of the TLR4 adaptor protein TRIF and reduced levels of the TLR4-inhibitor SIGIRR in the patients with ABU, but MyD88 and TRAM levels were not significantly altered. Altered TLR4 and adaptor protein expression might impair TLR4 signaling and explain the weak mucosal response to urinary tract infection in patients who develop ABU rather than symptomatic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597463     DOI: 10.1086/518893

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  [Urinary tract immunology].

Authors:  S Schubert
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

Review 4.  Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and meta-analysis of candidate gene polymorphisms.

Authors:  Marco Zaffanello; Stefano Tardivo; Luigi Cataldi; Vassilios Fanos; Paolo Biban; Giovanni Malerba
Journal:  Pediatr Nephrol       Date:  2010-11-30       Impact factor: 3.714

Review 5.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 6.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

7.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

Review 8.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

Review 9.  TLR-mediated immune responses in the urinary tract.

Authors:  Jeongmin Song; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2008-02-01       Impact factor: 7.934

10.  TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring.

Authors:  Meral Torun Bayram; Alper Soylu; Halil Ateş; Sefa Kızıldağ; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2013-04-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.